BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Orman ES, Li N, Shaheen NJ. Efficacy and durability of radiofrequency ablation for Barrett's Esophagus: systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2013;11:1245-1255. [PMID: 23644385 DOI: 10.1016/j.cgh.2013.03.039] [Cited by in Crossref: 180] [Cited by in F6Publishing: 135] [Article Influence: 22.5] [Reference Citation Analysis]
Number Citing Articles
1 Shah PM, Gerdes H. Endoscopic options for early stage esophageal cancer. J Gastrointest Oncol. 2015;6:20-30. [PMID: 25642334 DOI: 10.3978/j.issn.2078-6891.2014.096] [Cited by in F6Publishing: 17] [Reference Citation Analysis]
2 Rubenstein JH, Shaheen NJ. Epidemiology, Diagnosis, and Management of Esophageal Adenocarcinoma. Gastroenterology. 2015;149:302-17.e1. [PMID: 25957861 DOI: 10.1053/j.gastro.2015.04.053] [Cited by in Crossref: 182] [Cited by in F6Publishing: 175] [Article Influence: 30.3] [Reference Citation Analysis]
3 David WJ, Qumseya BJ, Qumsiyeh Y, Heckman MG, Diehl NN, Wallace MB, Raimondo M, Woodward TA, Wolfsen HC. Comparison of endoscopic treatment modalities for Barrett's neoplasia. Gastrointest Endosc 2015;82:793-803.e3. [PMID: 26071064 DOI: 10.1016/j.gie.2015.03.1979] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
4 Uno K, Iijima K, Koike T, Shimosegawa T. Useful strategies to prevent severe stricture after endoscopic submucosal dissection for superficial esophageal neoplasm. World J Gastroenterol 2015; 21(23): 7120-7133 [PMID: 26109798 DOI: 10.3748/wjg.v21.i23.7120] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
5 He S, Bergman J, Zhang Y, Weusten B, Xue L, Qin X, Dou L, Liu Y, Fleischer D, Lu N, Dawsey SM, Wang GQ. Endoscopic radiofrequency ablation for early esophageal squamous cell neoplasia: report of safety and effectiveness from a large prospective trial. Endoscopy. 2015;47:398-408. [PMID: 25668428 DOI: 10.1055/s-0034-1391285] [Cited by in Crossref: 35] [Cited by in F6Publishing: 30] [Article Influence: 5.8] [Reference Citation Analysis]
6 Cameron GR, Jayasekera CS, Williams R, Macrae FA, Desmond PV, Taylor AC. Detection and staging of esophageal cancers within Barrett's esophagus is improved by assessment in specialized Barrett's units. Gastrointestinal Endoscopy 2014;80:971-983.e1. [DOI: 10.1016/j.gie.2014.03.051] [Cited by in Crossref: 21] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
7 Visrodia K, Zakko L, Wang KK. Radiofrequency Ablation of Barrett's Esophagus: Efficacy, Complications, and Durability. Gastrointest Endosc Clin N Am 2017;27:491-501. [PMID: 28577770 DOI: 10.1016/j.giec.2017.03.003] [Cited by in Crossref: 5] [Article Influence: 1.3] [Reference Citation Analysis]
8 Rayner-Hartley E, Takach O, Galorport C, Enns RA. Diagnosis and Management of Barrett's Esophagus: A Retrospective Study Comparing the Endoscopic Assessment of Early Esophageal Lesions in the Community versus a Specialized Center. Can J Gastroenterol Hepatol 2016;2016:5749573. [PMID: 27446850 DOI: 10.1155/2016/5749573] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
9 Cholapranee A, Trindade AJ. Challenges in Endoscopic Therapy of Dysplastic Barrett's Esophagus. Curr Treat Options Gastroenterol 2019;17:32-47. [PMID: 30663018 DOI: 10.1007/s11938-019-00215-8] [Reference Citation Analysis]
10 Kahn A, Al-qaisi M, Kommineni VT, Callaway JK, Boroff ES, Burdick GE, Lam-himlin DM, Temkit M, Vela MF, Ramirez FC. Longitudinal outcomes of radiofrequency ablation versus surveillance endoscopy for Barrett's esophagus with low-grade dysplasia. Diseases of the Esophagus 2017;31. [DOI: 10.1093/dote/dox120] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
11 Luigiano C, Iabichino G, Eusebi LH, Arena M, Consolo P, Morace C, Opocher E, Mangiavillano B. Outcomes of Radiofrequency Ablation for Dysplastic Barrett's Esophagus: A Comprehensive Review. Gastroenterol Res Pract. 2016;2016:4249510. [PMID: 28070182 DOI: 10.1155/2016/4249510] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
12 Guthikonda A, Cotton CC, Madanick RD, Spacek MB, Moist SE, Ferrell K, Dellon ES, Shaheen NJ. Clinical Outcomes Following Recurrence of Intestinal Metaplasia After Successful Treatment of Barrett's Esophagus With Radiofrequency Ablation. Am J Gastroenterol 2017;112:87-94. [PMID: 27725648 DOI: 10.1038/ajg.2016.451] [Cited by in Crossref: 40] [Cited by in F6Publishing: 35] [Article Influence: 8.0] [Reference Citation Analysis]
13 Halland M, Katzka D, Iyer PG. Recent developments in pathogenesis, diagnosis and therapy of Barrett's esophagus. World J Gastroenterol 2015; 21(21): 6479-6490 [PMID: 26074687 DOI: 10.3748/wjg.v21.i21.6479] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
14 Dunbar KB, Spechler SJ. Controversies in Barrett esophagus. Mayo Clin Proc. 2014;89:973-984. [PMID: 24867396 DOI: 10.1016/j.mayocp.2014.01.022] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 1.9] [Reference Citation Analysis]
15 Manner H, Neugebauer A, Scharpf M, Braun K, May A, Ell C, Fend F, Enderle MD. The tissue effect of argon-plasma coagulation with prior submucosal injection (Hybrid-APC) versus standard APC: A randomized ex-vivo study. United European Gastroenterol J. 2014;2:383-390. [PMID: 25360316 DOI: 10.1177/2050640614544315] [Cited by in Crossref: 21] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
16 Cotton CC, Wolf WA, Pasricha S, Li N, Madanick RD, Spacek MB, Ferrell K, Dellon ES, Shaheen NJ. Recurrent intestinal metaplasia after radiofrequency ablation for Barrett's esophagus: endoscopic findings and anatomic location. Gastrointest Endosc 2015;81:1362-9. [PMID: 25817897 DOI: 10.1016/j.gie.2014.12.029] [Cited by in Crossref: 39] [Cited by in F6Publishing: 36] [Article Influence: 6.5] [Reference Citation Analysis]
17 Macías-García F, Domínguez-Muñoz JE. Update on management of Barrett's esophagus. World J Gastrointest Pharmacol Ther 2016; 7(2): 227-234 [PMID: 27158538 DOI: 10.4292/wjgpt.v7.i2.227] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
18 Pech O, Alqahtani SA. Update on endoscopic treatment of Barrett's oesophagus and Barrett's oesophagus-related neoplasia. Ther Adv Gastrointest Endosc 2020;13:2631774520935241. [PMID: 32783025 DOI: 10.1177/2631774520935241] [Reference Citation Analysis]
19 Ortiz-Fernández-Sordo J, Sami S, Mansilla-Vivar R, De Caestecker J, Cole A, Ragunath K. Incidence of metachronous visible lesions in patients referred for radiofrequency ablation (RFA) therapy for early Barrett's neoplasia: a single-centre experience. Frontline Gastroenterol 2016;7:24-9. [PMID: 26834956 DOI: 10.1136/flgastro-2015-100561] [Cited by in Crossref: 3] [Article Influence: 0.6] [Reference Citation Analysis]
20 Eluri S, Paterson A, Lauren BN, O'Donovan M, Bhandari P, di Pietro M, Lee M, Haidry R, Lovat L, Ragunath K, Hur C, Fitzgerald RC, Shaheen NJ. Utility and Cost-Effectiveness of a Nonendoscopic Approach to Barrett's Esophagus Surveillance After Endoscopic Therapy. Clin Gastroenterol Hepatol 2021:S1542-3565(21)00147-6. [PMID: 33581357 DOI: 10.1016/j.cgh.2021.02.013] [Reference Citation Analysis]
21 Zeki SS, Bergman JJ, Dunn JM. Endoscopic management of dysplasia and early oesophageal cancer. Best Pract Res Clin Gastroenterol 2018;36-37:27-36. [PMID: 30551853 DOI: 10.1016/j.bpg.2018.11.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
22 Sanghi V, Thota PN. Barrett's esophagus: novel strategies for screening and surveillance. Ther Adv Chronic Dis 2019;10:2040622319837851. [PMID: 30937155 DOI: 10.1177/2040622319837851] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
23 Brown J, Alsop B, Gupta N, Buckles DC, Olyaee MS, Vennalaganti P, Kanakadandi VN, Saligram S, Sharma P. Effectiveness of focal vs. balloon radiofrequency ablation devices in the treatment of Barrett's esophagus. United European Gastroenterol J 2016;4:236-41. [PMID: 27087952 DOI: 10.1177/2050640615594549] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.2] [Reference Citation Analysis]
24 Rieder E, Riegler M, Simić AP, Skrobić OM, Bonavina L, Gurski R, Paireder M, Castell DO, Schoppmann SF. Alternative therapies for GERD: a way to personalized antireflux surgery. Ann N Y Acad Sci 2018;1434:360-9. [PMID: 29774563 DOI: 10.1111/nyas.13851] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 3.7] [Reference Citation Analysis]
25 Hamade N, Sharma P. Ablation Therapy for Barrett's Esophagus: New Rules for Changing Times. Curr Gastroenterol Rep 2017;19:48. [PMID: 28819902 DOI: 10.1007/s11894-017-0589-2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
26 Sehgal V, Ragunath K, Haidry R. Measuring Quality in Barrett's Esophagus: Time to Embrace Quality Indicators. Gastrointest Endosc Clin N Am 2021;31:219-36. [PMID: 33213797 DOI: 10.1016/j.giec.2020.09.006] [Reference Citation Analysis]
27 Wani S, Rubenstein JH, Vieth M, Bergman J. Diagnosis and Management of Low-Grade Dysplasia in Barrett's Esophagus: Expert Review From the Clinical Practice Updates Committee of the American Gastroenterological Association. Gastroenterology 2016;151:822-35. [PMID: 27702561 DOI: 10.1053/j.gastro.2016.09.040] [Cited by in Crossref: 77] [Cited by in F6Publishing: 65] [Article Influence: 15.4] [Reference Citation Analysis]
28 Brimhall B, Wani S. Current Endoscopic Approaches for the Treatment of Barrett Esophagus. Journal of Clinical Gastroenterology 2017;51:2-11. [DOI: 10.1097/mcg.0000000000000742] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
29 Blevins CH, Iyer PG. Endoscopic therapy for Barrett's oesophagus. Best Practice & Research Clinical Gastroenterology 2015;29:167-77. [DOI: 10.1016/j.bpg.2014.11.007] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
30 Manner H, May A, Kouti I, Pech O, Vieth M, Ell C. Efficacy and safety of Hybrid-APC for the ablation of Barrett's esophagus. Surg Endosc. 2016;30:1364-1370. [PMID: 26104794 DOI: 10.1007/s00464-015-4336-1] [Cited by in Crossref: 40] [Cited by in F6Publishing: 29] [Article Influence: 6.7] [Reference Citation Analysis]
31 Navaneethan U, Thosani N, Goodman A, Manfredi M, Pannala R, Parsi MA, Smith ZL, Sullivan SA, Banerjee S, Maple JT; ASGE Technology Committee. Radiofrequency ablation devices. VideoGIE 2017;2:252-9. [PMID: 29905337 DOI: 10.1016/j.vgie.2017.06.002] [Cited by in Crossref: 17] [Cited by in F6Publishing: 10] [Article Influence: 4.3] [Reference Citation Analysis]
32 Spiceland CM, Elmunzer BJ, Paros S, Roof L, McVey M, Hawes R, Hoffman BJ, Elias PS. Salvage cryotherapy in patients undergoing endoscopic eradication therapy for complicated Barrett's esophagus. Endosc Int Open. 2019;7:E904-E911. [PMID: 31281876 DOI: 10.1055/a-0902-4587] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
33 Mohan BP, Krishnamoorthi R, Ponnada S, Shakhatreh M, Jayaraj M, Garg R, Law J, Larsen M, Irani S, Ross A, Adler DG. Liquid Nitrogen Spray Cryotherapy in Treatment of Barrett's Esophagus, where do we stand? A Systematic Review and Meta-Analysis. Dis Esophagus 2019;32:doy130. [PMID: 30715267 DOI: 10.1093/dote/doy130] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
34 Medina AL, Troendle DM, Park JY, Thaker A, Dunbar KB, Cheng E. Eosinophilic esophagitis, Barrett's esophagus and esophageal neoplasms in the pediatric patient: a narrative review. Transl Gastroenterol Hepatol 2021;6:32. [PMID: 34423153 DOI: 10.21037/tgh-20-223] [Reference Citation Analysis]
35 Tsibouris P, Vlachou E, Isaacs PET. Role of chemoprophylaxis with either NSAIDs or statins in patients with Barrett’s esophagus. World J Gastrointest Pharmacol Ther 2014; 5(1): 27-39 [PMID: 24605249 DOI: 10.4292/wjgpt.v5.i1.27] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.1] [Reference Citation Analysis]
36 Alzoubaidi D, Hussein M, Sehgal V, Makahamadze C, Magee CG, Everson M, Graham D, Sweis R, Banks M, Sami SS, Novelli M, Lovat L, Haidry R. Cryoballoon ablation for treatment of patients with refractory esophageal neoplasia after first line endoscopic eradication therapy. Endosc Int Open 2020;8:E891-9. [PMID: 32665972 DOI: 10.1055/a-1149-1414] [Reference Citation Analysis]
37 Kaimakliotis PZ, Falk GW. Radiofrequency ablation for Barrett's esophagus. Curr Opin Gastroenterol 2014;30:415-21. [PMID: 24867156 DOI: 10.1097/MOG.0000000000000087] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
38 Wani S, Qumseya B, Sultan S, Agrawal D, Chandrasekhara V, Harnke B, Kothari S, Mccarter M, Shaukat A, Wang A, Yang J, Dewitt J. Endoscopic eradication therapy for patients with Barrett’s esophagus–associated dysplasia and intramucosal cancer. Gastrointestinal Endoscopy 2018;87:907-931.e9. [DOI: 10.1016/j.gie.2017.10.011] [Cited by in Crossref: 59] [Cited by in F6Publishing: 39] [Article Influence: 19.7] [Reference Citation Analysis]
39 Pouw RE, Bergman JJ. Radiofrequency ablation for Barrett's esophagus, for whom and by whom? Clin Gastroenterol Hepatol 2013;11:1256-8. [PMID: 23811256 DOI: 10.1016/j.cgh.2013.06.014] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
40 Verheij EPD, van Munster SN, Pouw RE. Recurrent intestinal metaplasia in the gastroesophageal junction after endoscopic eradication of Barrett's: Is ignorance bliss? Gastrointest Endosc 2021;93:1258-60. [PMID: 33691981 DOI: 10.1016/j.gie.2020.12.025] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
41 Pouw RE, Klaver E, Phoa KN, van Vilsteren FG, Weusten BL, Bisschops R, Schoon EJ, Pech O, Manner H, Ragunath K, Fernández-Sordo JO, Fullarton G, Di Pietro M, Januszewicz W, O'Toole D, Bergman JJ. Radiofrequency ablation for low-grade dysplasia in Barrett's esophagus: long-term outcome of a randomized trial. Gastrointest Endosc 2020;92:569-74. [PMID: 32217112 DOI: 10.1016/j.gie.2020.03.3756] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 9.0] [Reference Citation Analysis]
42 Trindade AJ, Inamdar S, Kothari S, Berkowitz J, McKinley M, Kaul V. Feasibility of liquid nitrogen cryotherapy after failed radiofrequency ablation for Barrett's esophagus. Dig Endosc. 2017;29:680-685. [PMID: 28303613 DOI: 10.1111/den.12869] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 5.5] [Reference Citation Analysis]
43 Ross-Innes CS, Becq J, Warren A, Cheetham RK, Northen H, O'Donovan M, Malhotra S, di Pietro M, Ivakhno S, He M, Weaver JMJ, Lynch AG, Kingsbury Z, Ross M, Humphray S, Bentley D, Fitzgerald RC. Whole-genome sequencing provides new insights into the clonal architecture of Barrett's esophagus and esophageal adenocarcinoma. Nat Genet. 2015;47:1038-1046. [PMID: 26192915 DOI: 10.1038/ng.3357] [Cited by in Crossref: 168] [Cited by in F6Publishing: 154] [Article Influence: 28.0] [Reference Citation Analysis]
44 Hamade N, Desai M, Thoguluva Chandrasekar V, Chalhoub J, Patel M, Duvvuri A, Gorrepati VS, Jegadeesan R, Choudhary A, Sathyamurthy A, Rai T, Gupta N, Sharma P. Efficacy of cryotherapy as first line therapy in patients with Barrett's neoplasia: a systematic review and pooled analysis. Dis Esophagus 2019;32:doz040. [PMID: 31076753 DOI: 10.1093/dote/doz040] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
45 Lovat L. The new treatment paradigm for Barrett's dysplasia. Frontline Gastroenterol 2016;7:30-1. [PMID: 28839831 DOI: 10.1136/flgastro-2015-100584] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
46 Fujii-Lau LL, Cinnor B, Shaheen N, Gaddam S, Komanduri S, Muthusamy VR, Das A, Wilson R, Simon VC, Kushnir V, Mullady D, Edmundowicz SA, Early DS, Wani S. Recurrence of intestinal metaplasia and early neoplasia after endoscopic eradication therapy for Barrett's esophagus: a systematic review and meta-analysis. Endosc Int Open 2017;5:E430-49. [PMID: 28573176 DOI: 10.1055/s-0043-106578] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 6.3] [Reference Citation Analysis]
47 Mitchell DP, Yeluri S, Van der Wall H, Falk GL. The real risk of nodal disease in T1 oesophageal adenocarcinoma: A systematic review. Eur Surg 2020;52:110-7. [DOI: 10.1007/s10353-019-00627-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
48 di Pietro M, Canto MI, Fitzgerald RC. Endoscopic Management of Early Adenocarcinoma and Squamous Cell Carcinoma of the Esophagus: Screening, Diagnosis, and Therapy. Gastroenterology. 2018;154:421-436. [PMID: 28778650 DOI: 10.1053/j.gastro.2017.07.041] [Cited by in Crossref: 64] [Cited by in F6Publishing: 66] [Article Influence: 16.0] [Reference Citation Analysis]
49 Visrodia K, Zakko L, Wang KK. Mucosal Ablation in Patients with Barrett's Esophagus: Fry or Freeze? Dig Dis Sci 2018;63:2129-35. [PMID: 29777441 DOI: 10.1007/s10620-018-5064-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
50 Raphael KL, Trindade AJ. Management of Barrett’s esophagus with dysplasia refractory to radiofrequency ablation. World J Gastroenterol 2020; 26(17): 2030-2039 [PMID: 32536772 DOI: 10.3748/wjg.v26.i17.2030] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
51 Wani S, Muthusamy VR, Shaheen NJ, Yadlapati R, Wilson R, Abrams JA, Bergman J, Chak A, Chang K, Das A, Dumot J, Edmundowicz SA, Eisen G, Falk GW, Fennerty MB, Gerson L, Ginsberg GG, Grande D, Hall M, Harnke B, Inadomi J, Jankowski J, Lightdale CJ, Makker J, Odze RD, Pech O, Sampliner RE, Spechler S, Triadafilopoulos G, Wallace MB, Wang K, Waxman I, Komanduri S. Development of quality indicators for endoscopic eradication therapies in Barrett’s esophagus: the TREAT-BE (Treatment with Resection and Endoscopic Ablation Techniques for Barrett’s Esophagus) Consortium. Gastrointestinal Endoscopy 2017;86:1-17.e3. [DOI: 10.1016/j.gie.2017.03.010] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 5.8] [Reference Citation Analysis]
52 Rajaram R, Hofstetter WL. Mucosal Ablation Techniques for Barrett's Esophagus and Early Esophageal Cancer. Thorac Surg Clin 2018;28:473-80. [PMID: 30268293 DOI: 10.1016/j.thorsurg.2018.07.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
53 Eluri S, Shaheen NJ. Endoscopic Eradication Therapy in Barrett's Esophagus. Tech Gastrointest Endosc. 2017;19:137-142. [PMID: 29269998 DOI: 10.1016/j.tgie.2017.06.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
54 Stier MW, Lodhia N, Jacobs J, Nozicka D, Kavitt R, Siddiqui U, Waxman I, Konda VJ. Perceptions of risk and therapy among patients with Barrett's esophagus: a patient survey study. Diseases of the Esophagus 2017;31. [DOI: 10.1093/dote/dox109] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
55 Ramay FH, Cui Q, Greenwald BD. Outcomes after liquid nitrogen spray cryotherapy in Barrett's esophagus-associated high-grade dysplasia and intramucosal adenocarcinoma: 5-year follow-up. Gastrointest Endosc. 2017;86:626-632. [PMID: 28235596 DOI: 10.1016/j.gie.2017.02.006] [Cited by in Crossref: 38] [Cited by in F6Publishing: 30] [Article Influence: 9.5] [Reference Citation Analysis]
56 Thrift AP. Global burden and epidemiology of Barrett oesophagus and oesophageal cancer. Nat Rev Gastroenterol Hepatol 2021;18:432-43. [PMID: 33603224 DOI: 10.1038/s41575-021-00419-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 10.0] [Reference Citation Analysis]
57 Cameron GR, Desmond PV, Jayasekera CS, Amico F, Williams R, Macrae FA, Taylor AC. Recurrent intestinal metaplasia at the gastroesophageal junction following endoscopic eradication of dysplastic Barrett's esophagus may not be benign. Endosc Int Open 2016;4:E849-58. [PMID: 27540572 DOI: 10.1055/s-0042-109608] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
58 Naini BV, Souza RF, Odze RD. Barrett's Esophagus: A Comprehensive and Contemporary Review for Pathologists. Am J Surg Pathol. 2016;40:e45-e66. [PMID: 26813745 DOI: 10.1097/pas.0000000000000598] [Cited by in Crossref: 54] [Cited by in F6Publishing: 25] [Article Influence: 10.8] [Reference Citation Analysis]
59 Malik S, Sharma G, Sanaka MR, Thota PN. Role of endoscopic therapy in early esophageal cancer. World J Gastroenterol 2018; 24(35): 3965-3973 [PMID: 30254401 DOI: 10.3748/wjg.v24.i35.3965] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
60 Goldstone RN, Hasan SR, Drury S, Darragh TM, van Zante A, Goldstone SE. A trial of radiofrequency ablation for anal intraepithelial neoplasia. Int J Colorectal Dis 2017;32:357-65. [DOI: 10.1007/s00384-016-2679-2] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.2] [Reference Citation Analysis]
61 Thoguluva Chandrasekar V, Vennalaganti P, Sharma P. Management of Barrett's esophagus: From screening to newer treatments. Rev Gastroenterol Mex 2016;81:91-102. [PMID: 26964773 DOI: 10.1016/j.rgmx.2015.07.007] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
62 Skrobić O, Simić A, Radovanović N, Ivanović N, Micev M, Peško P. Significance of Nissen fundoplication after endoscopic radiofrequency ablation of Barrett's esophagus. Surg Endosc 2016;30:3802-7. [PMID: 26659238 DOI: 10.1007/s00464-015-4677-9] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
63 Martinucci I, de Bortoli N, Russo S, Bertani L, Furnari M, Mokrowiecka A, Malecka-Panas E, Savarino V, Savarino E, Marchi S. Barrett’s esophagus in 2016: From pathophysiology to treatment. World J Gastrointest Pharmacol Ther 2016; 7(2): 190-206 [PMID: 27158534 DOI: 10.4292/wjgpt.v7.i2.190] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
64 Reed CC, Shaheen NJ. Natural History of the Post-ablation Esophagus. Dig Dis Sci 2018;63:2136-45. [DOI: 10.1007/s10620-018-5066-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
65 Kia L, Komanduri S. Care of the Postablation Patient. Gastrointestinal Endoscopy Clinics of North America 2017;27:515-29. [DOI: 10.1016/j.giec.2017.02.008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
66 Iyer PG. A "deeper" look at subsquamous structures beneath the neosquamous epithelium after Barrett's esophagus endotherapy. Gastrointest Endosc 2016;83:89-91. [PMID: 26706299 DOI: 10.1016/j.gie.2015.08.061] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
67 Omidvari A, Roumans CA, Naber SK, Kroep S, Wijnhoven BP, Gaast AVD, de Jonge P, Spaander MC, Lansdorp-vogelaar I. The Impact of the Policy-Practice Gap on Costs and Benefits of Barrett's Esophagus Management. Am J Gastroenterol 2020;115:1026-35. [DOI: 10.14309/ajg.0000000000000578] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
68 Ganz RA, Mitlyng B, Leon S. The case for ablating nondysplastic Barrett’s esophagus. Gastrointest Endosc. 2014;80:866-872. [PMID: 25436398 DOI: 10.1016/j.gie.2014.06.010] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
69 Tariq R, Enslin S, Hayat M, Kaul V. Efficacy of Cryotherapy as a Primary Endoscopic Ablation Modality for Dysplastic Barrett's Esophagus and Early Esophageal Neoplasia: A Systematic Review and Meta-Analysis. Cancer Control 2020;27:1073274820976668. [PMID: 33297725 DOI: 10.1177/1073274820976668] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
70 Lei S, Mulmi Shrestha S, Shi R. Radiofrequency Ablation for Early Superficial Flat Esophageal Squamous Cell Neoplasia: A Comprehensive Review. Gastroenterol Res Pract 2020;2020:4152453. [PMID: 32508911 DOI: 10.1155/2020/4152453] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
71 Mizrahi M, Sengupta N, Pleskow DK, Chuttani R, Sawhney MS, Berzin TM. Minor Anesthesia-Related Events During Radiofrequency Ablation for Barrett's Esophagus Are Associated with an Increased Number of Treatment Sessions. Dig Dis Sci 2016;61:1591-6. [PMID: 26894399 DOI: 10.1007/s10620-016-4059-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
72 O’byrne LM, Witherspoon J, Verhage RJJ, O’brien M, Muldoon C, Ryan C, Buckley M, Murphy T, Reynolds R, Patchett S, Kay E, Azam H, Robb W, Arumugasamy M, Mathuna PM, Leyden J, Gargan S, Doherty G, Sheahan K, Collins C, Nath A, O’sullivan J, Donohoe CL, Ravi N, O’toole D, Reynolds JV. Barrett’s Registry Collaboration of academic centers in Ireland reveals high progression rate of low-grade dysplasia and low risk from nondysplastic Barrett’s esophagus: report of the RIBBON network. Diseases of the Esophagus 2020;33:doaa009. [DOI: 10.1093/dote/doaa009] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
73 Evans RPT, Mourad MM, Fisher SG, Bramhall SR. Evolving management of metaplasia and dysplasia in Barrett's epithelium. World J Gastroenterol 2016; 22(47): 10316-10324 [PMID: 28058012 DOI: 10.3748/wjg.v22.i47.10316] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
74 Thota PN, Arora Z, Dumot JA, Falk G, Benjamin T, Goldblum J, Jang S, Lopez R, Vargo JJ. Cryotherapy and Radiofrequency Ablation for Eradication of Barrett's Esophagus with Dysplasia or Intramucosal Cancer. Dig Dis Sci. 2018;63:1311-1319. [PMID: 29524114 DOI: 10.1007/s10620-018-5009-4] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 6.7] [Reference Citation Analysis]
75 Leclercq P, Bisschops R. Optimizing Outcomes with Radiofrequency Ablation of Barrett's Esophagus: Candidates, Efficacy and Durability. Gastrointest Endosc Clin N Am 2021;31:131-54. [PMID: 33213792 DOI: 10.1016/j.giec.2020.09.004] [Reference Citation Analysis]
76 Desai M, Rösch T, Sundaram S, Chandrasekar VT, Kohli D, Spadaccini M, Hassan C, Repici A, Sharma P. Systematic review with meta-analysis: the long-term efficacy of Barrett's endoscopic therapy-stringent selection criteria and a proposal for definitions. Aliment Pharmacol Ther 2021;54:222-33. [PMID: 34165205 DOI: 10.1111/apt.16473] [Reference Citation Analysis]
77 Houston T, Sharma P. Volumetric laser endomicroscopy in Barrett's esophagus: ready for primetime. Transl Gastroenterol Hepatol. 2020;5:27. [PMID: 32258531 DOI: 10.21037/tgh.2019.11.16] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
78 Soroush A, Poneros JM, Lightdale CJ, Abrams JA. Shorter time to achieve endoscopic eradication is not associated with improved long-term outcomes in Barrett's esophagus. Diseases of the Esophagus 2019;32:doz026. [DOI: 10.1093/dote/doz026] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
79 Brown CS, Lapin B, Goldstein JL, Linn JG, Talamonti MS, Carbray J, Ujiki MB. Predicting Progression in Barrett's Esophagus: Development and Validation of the Barrett's Esophagus Assessment of Risk Score (BEAR Score). Annals of Surgery 2018;267:716-20. [DOI: 10.1097/sla.0000000000002179] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 2.3] [Reference Citation Analysis]
80 Vance RB, Dunbar KB. Endoscopic options for treatment of dysplasia in Barrett’s esophagus. World J Gastrointest Endosc 2015; 7(19): 1311-1317 [PMID: 26722612 DOI: 10.4253/wjge.v7.i19.1311] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
81 Ramai D, Lai JK, Ofori E, Linn S, Reddy M. Evaluation and Management of Premalignant Conditions of the Esophagus: A Systematic Survey of International Guidelines. Journal of Clinical Gastroenterology 2019;53:627-34. [DOI: 10.1097/mcg.0000000000001247] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
82 Peters Y, Al-kaabi A, Shaheen NJ, Chak A, Blum A, Souza RF, Di Pietro M, Iyer PG, Pech O, Fitzgerald RC, Siersema PD. Barrett oesophagus. Nat Rev Dis Primers 2019;5. [DOI: 10.1038/s41572-019-0086-z] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 13.5] [Reference Citation Analysis]
83 Komanduri S, Muthusamy VR, Wani S. Controversies in Endoscopic Eradication Therapy for Barrett’s Esophagus. Gastroenterology 2018;154:1861-1875.e1. [DOI: 10.1053/j.gastro.2017.12.045] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
84 Chedgy FJ, Kandiah K, Thayalasekaran S, Subramaniam S, Bhandari P. Advances in the endoscopic diagnosis and treatment of Barrett's neoplasia. F1000Res 2016;5:F1000 Faculty Rev-113. [PMID: 26918175 DOI: 10.12688/f1000research.6996.1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
85 Lee HC, Ahsen OO, Liu JJ, Tsai TH, Huang Q, Mashimo H, Fujimoto JG. Assessment of the radiofrequency ablation dynamics of esophageal tissue with optical coherence tomography. J Biomed Opt. 2017;22:76001. [PMID: 28687822 DOI: 10.1117/1.jbo.22.7.076001] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
86 Canto MI, Trindade AJ, Abrams J, Rosenblum M, Dumot J, Chak A, Iyer P, Diehl D, Khara HS, Corbett FS, McKinley M, Shin EJ, Waxman I, Infantolino A, Tofani C, Samarasena J, Chang K, Wang B, Goldblum J, Voltaggio L, Montgomery E, Lightdale CJ, Shaheen NJ. Multifocal Cryoballoon Ablation for Eradication of Barrett's Esophagus-Related Neoplasia: A Prospective Multicenter Clinical Trial. Am J Gastroenterol 2020;115:1879-90. [PMID: 33156107 DOI: 10.14309/ajg.0000000000000822] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
87 Jones B, Wani S. Endoscopic Eradication Therapy for Barrett's Neoplasia: Where Do We Stand a Decade Later? Curr Gastroenterol Rep 2020;22:61. [PMID: 33277663 DOI: 10.1007/s11894-020-00799-7] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
88 Pasricha S, Bulsiewicz WJ, Hathorn KE, Komanduri S, Muthusamy VR, Rothstein RI, Wolfsen HC, Lightdale CJ, Overholt BF, Camara DS. Durability and predictors of successful radiofrequency ablation for Barrett’s esophagus. Clin Gastroenterol Hepatol. 2014;12:1840-7.e1. [PMID: 24815329 DOI: 10.1016/j.cgh.2014.04.034] [Cited by in Crossref: 77] [Cited by in F6Publishing: 66] [Article Influence: 11.0] [Reference Citation Analysis]
89 Visrodia K, Zakko L, Singh S, Leggett CL, Iyer PG, Wang KK. Cryotherapy for persistent Barrett's esophagus after radiofrequency ablation: a systematic review and meta-analysis. Gastrointest Endosc 2018;87:1396-1404.e1. [PMID: 29476849 DOI: 10.1016/j.gie.2018.02.021] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 9.3] [Reference Citation Analysis]
90 Inadomi J, Alastal H, Bonavina L, Gross S, Hunt RH, Mashimo H, di Pietro M, Rhee H, Shah M, Tolone S, Wang DH, Xie SH. Recent advances in Barrett's esophagus. Ann N Y Acad Sci 2018;1434:227-38. [PMID: 29974975 DOI: 10.1111/nyas.13909] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
91 Zagari RM, Eusebi LH, Galloro G, Rabitti S, Neri M, Pasquale L, Bazzoli F. Attending Training Courses on Barrett's Esophagus Improves Adherence to Guidelines: A Survey from the Italian Society of Digestive Endoscopy. Dig Dis Sci 2021;66:2888-96. [PMID: 32984930 DOI: 10.1007/s10620-020-06615-6] [Reference Citation Analysis]
92 Parasa S, Sharma P. Endoscopic Therapy for Barrett's Esophagus: Should We Also Be Treating the Squamous Mucosa? Clin Gastroenterol Hepatol 2014;12:411-3. [PMID: 24184735 DOI: 10.1016/j.cgh.2013.10.027] [Reference Citation Analysis]
93 Eluri S, Earasi AG, Moist SE, Dellon ES, Shaheen NJ. Prevalence and Incidence of Intestinal Metaplasia and Dysplasia of Gastric Cardia in Patients With Barrett's Esophagus After Endoscopic Therapy. Clin Gastroenterol Hepatol 2020;18:82-88.e1. [PMID: 31077822 DOI: 10.1016/j.cgh.2019.04.065] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
94 Condon A, Muthusamy VR. The evolution of endoscopic therapy for Barrett's esophagus. Ther Adv Gastrointest Endosc 2021;14:26317745211051834. [PMID: 34708204 DOI: 10.1177/26317745211051834] [Reference Citation Analysis]
95 Ohki T, Yamamoto M. Esophageal regenerative therapy using cell sheet technology. Regen Ther 2020;13:8-17. [PMID: 33490318 DOI: 10.1016/j.reth.2020.04.009] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
96 Wani S, Sharma P. Challenges with Endoscopic Therapy for Barrett's Esophagus. Gastroenterol Clin North Am 2015;44:355-72. [PMID: 26021199 DOI: 10.1016/j.gtc.2015.02.007] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
97 Hu Y, Puri V, Shami VM, Stukenborg GJ, Kozower BD. Comparative Effectiveness of Esophagectomy Versus Endoscopic Treatment for Esophageal High-grade Dysplasia. Ann Surg. 2016;263:719-726. [PMID: 26672723 DOI: 10.1097/sla.0000000000001387] [Cited by in Crossref: 21] [Cited by in F6Publishing: 10] [Article Influence: 4.2] [Reference Citation Analysis]
98 Akiyama J, Komanduri S, Konda VJ, Mashimo H, Noria S, Triadafilopoulos G. Endoscopy for diagnosis and treatment in esophageal cancers: high-technology assessment. Ann N Y Acad Sci 2014;1325:77-88. [PMID: 25266017 DOI: 10.1111/nyas.12526] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
99 Kahn A, Shaheen NJ, Iyer PG. Approach to the Post-Ablation Barrett's Esophagus Patient. Am J Gastroenterol 2020;115:823-31. [PMID: 31899706 DOI: 10.14309/ajg.0000000000000514] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
100 Omidvari AH, Hazelton WD, Lauren BN, Naber SK, Lee M, Ali A, Seguin C, Kong CY, Richmond E, Rubenstein JH, Luebeck GE, Inadomi JM, Hur C, Lansdorp-Vogelaar I. The Optimal Age to Stop Endoscopic Surveillance of Patients With Barrett's Esophagus Based on Sex and Comorbidity: A Comparative Cost-Effectiveness Analysis. Gastroenterology 2021;161:487-494.e4. [PMID: 33974935 DOI: 10.1053/j.gastro.2021.05.003] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
101 Gross SA, Sharma P. Recurrence of Cancer After Endoscopic Ablation of Barrett’s Esophagus: Is the Elephant in the Room…Persistent Ongoing Reflux? Dig Dis Sci 2014;59:1354-5. [DOI: 10.1007/s10620-014-3110-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
102 Qumseya B, David W, McCrum M, Dong Y, Raimondo M, Woodward TA, Wallace MB, Wolfsen HC. Gender differences in remission of esophageal intestinal metaplasia after radiofrequency ablation. Am J Gastroenterol. 2014;109:369-374. [PMID: 24394753 DOI: 10.1038/ajg.2013.454] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
103 Mueller CL, Ferri LE. Endoluminal therapies for Barrett’s esophagus. OBES SURG 2016;26:721-6. [DOI: 10.1007/s11695-015-2010-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
104 Tuttle R, Nurkin SJ, Hochwald SN. Ablative therapy for esophageal dysplasia and early malignancy: focus on RFA. Biomed Res Int 2014;2014:642063. [PMID: 25140320 DOI: 10.1155/2014/642063] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
105 Tomizawa Y, Konda VJ, Coronel E, Chapman CG, Siddiqui UD. Efficacy, Durability, and Safety of Complete Endoscopic Mucosal Resection of Barrett Esophagus: A Systematic Review and Meta-Analysis. Journal of Clinical Gastroenterology 2018;52:210-6. [DOI: 10.1097/mcg.0000000000000800] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
106 Shen XJ, Liu L, Zhu JY. Radiofrequency ablation in a patient with radiation enteritis: A case report. Medicine (Baltimore) 2018;97:e13328. [PMID: 30461649 DOI: 10.1097/MD.0000000000013328] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
107 Haidry R, Lovat L, Sharma P. Radiofrequency ablation for Barrett's dysplasia: past, present and the future? Curr Gastroenterol Rep 2015;17:13. [PMID: 25740248 DOI: 10.1007/s11894-015-0433-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
108 Thota PN, Sada A, Sanaka MR, Jang S, Lopez R, Goldblum JR, Liu X, Dumot JA, Vargo J, Zuccarro G. Correlation between endoscopic forceps biopsies and endoscopic mucosal resection with endoscopic ultrasound in patients with Barrett's esophagus with high-grade dysplasia and early cancer. Surg Endosc 2017;31:1336-41. [PMID: 27444824 DOI: 10.1007/s00464-016-5117-1] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 3.4] [Reference Citation Analysis]
109 Cotton RG, Langer R, Leong T, Martinek J, Sewram V, Smithers M, Swanson PE, Qiao Y, Udagawa H, Ueno M, Wang M, Wei W, White RE. Coping with esophageal cancer approaches worldwide: Coping with esophageal cancer. Ann N Y Acad Sci 2014;1325:138-58. [DOI: 10.1111/nyas.12522] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
110 Timmer MR, Martinez P, Lau CT, Westra WM, Calpe S, Rygiel AM, Rosmolen WD, Meijer SL, Ten Kate FJ, Dijkgraaf MG, Mallant-Hent RC, Naber AH, van Oijen AH, Baak LC, Scholten P, Böhmer CJ, Fockens P, Maley CC, Graham TA, Bergman JJ, Krishnadath KK. Derivation of genetic biomarkers for cancer risk stratification in Barrett's oesophagus: a prospective cohort study. Gut 2016;65:1602-10. [PMID: 26104750 DOI: 10.1136/gutjnl-2015-309642] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 4.2] [Reference Citation Analysis]
111 Watson TJ. Esophagectomy for Superficial Esophageal Neoplasia. Gastrointest Endosc Clin N Am 2017;27:531-46. [PMID: 28577773 DOI: 10.1016/j.giec.2017.02.009] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
112 Qumseya BJ, Wani S, Desai M, Qumseya A, Bain P, Sharma P, Wolfsen H. Adverse Events After Radiofrequency Ablation in Patients With Barrett's Esophagus: A Systematic Review and Meta-analysis. Clin Gastroenterol Hepatol. 2016;14:1086-1095.e6. [PMID: 27068041 DOI: 10.1016/j.cgh.2016.04.001] [Cited by in Crossref: 78] [Cited by in F6Publishing: 56] [Article Influence: 15.6] [Reference Citation Analysis]
113 Wani S, Muthusamy RV, Shaheen NJ, Yadlapati R, Wilson R, Abrams JA, Bergman J, Chak A, Chang K, Das A, Dumot J, Edmundowicz SA, Eisen G, Falk GW, Fennerty BM, Gerson L, Ginsberg GG, Grande D, Hall M, Harnke B, Inadomi J, Jankowski J, Lightdale CJ, Makker J, Odze RD, Pech O, Sampliner RE, Spechler S, Triadafilopoulos G, Wallace MB, Wang K, Waxman I, Komanduri S. Development of Quality Indicators for Endoscopic Eradication Therapies in Barrett’s Esophagus: The TREAT-BE (Treatment With Resection and Endoscopic Ablation Techniques for Barrett’s Esophagus) Consortium. American Journal of Gastroenterology 2017;112:1032-48. [DOI: 10.1038/ajg.2017.166] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 5.5] [Reference Citation Analysis]
114 Canto MI, Shaheen NJ, Almario JA, Voltaggio L, Montgomery E, Lightdale CJ. Multifocal nitrous oxide cryoballoon ablation with or without EMR for treatment of neoplastic Barrett's esophagus (with video). Gastrointest Endosc. 2018;88:438-446.e2. [PMID: 29626424 DOI: 10.1016/j.gie.2018.03.024] [Cited by in Crossref: 34] [Cited by in F6Publishing: 27] [Article Influence: 11.3] [Reference Citation Analysis]
115 Small AJ, Araujo JL, Leggett CL, Mendelson AH, Agarwalla A, Abrams JA, Lightdale CJ, Wang TC, Iyer PG, Wang KK, Rustgi AK, Ginsberg GG, Forde KA, Gimotty PA, Lewis JD, Falk GW, Bewtra M. Radiofrequency Ablation Is Associated With Decreased Neoplastic Progression in Patients With Barrett's Esophagus and Confirmed Low-Grade Dysplasia. Gastroenterology. 2015;149:567-76.e3; quiz e13-4. [PMID: 25917785 DOI: 10.1053/j.gastro.2015.04.013] [Cited by in Crossref: 49] [Cited by in F6Publishing: 38] [Article Influence: 8.2] [Reference Citation Analysis]
116 Amadi C, Gatenby P. Barrett’s oesophagus: Current controversies. World J Gastroenterol 2017; 23(28): 5051-5067 [PMID: 28811703 DOI: 10.3748/wjg.v23.i28.5051] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
117 Golger D, Probst A, Messmann H. Barrett's esophagus: lessons from recent clinical trials. Ann Gastroenterol 2016;29:417-23. [PMID: 27708506 DOI: 10.20524/aog.2016.0070] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
118 Barret M, Beye B, Leblanc S, Beuvon F, Chaussade S, Batteux F, Prat F. Systematic review: the prevention of oesophageal stricture after endoscopic resection. Aliment Pharmacol Ther 2015;42:20-39. [DOI: 10.1111/apt.13254] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 3.5] [Reference Citation Analysis]
119 Ortiz-Fernandez-Sordo J, Sami SS, Mansilla-Vivar R, Subramanian V, Mannath J, Telakis E, Ragunath K. Evaluation of a novel infra-red endoscopy system in the assessment of early neoplasia in Barretts esophagus: pilot study from a single center. Dis Esophagus. 2018;31. [PMID: 29228128 DOI: 10.1093/dote/dox137] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
120 Martinez P, Timmer MR, Lau CT, Calpe S, Sancho-Serra Mdel C, Straub D, Baker AM, Meijer SL, Kate FJ, Mallant-Hent RC, Naber AH, van Oijen AH, Baak LC, Scholten P, Böhmer CJ, Fockens P, Bergman JJ, Maley CC, Graham TA, Krishnadath KK. Dynamic clonal equilibrium and predetermined cancer risk in Barrett's oesophagus. Nat Commun 2016;7:12158. [PMID: 27538785 DOI: 10.1038/ncomms12158] [Cited by in Crossref: 55] [Cited by in F6Publishing: 52] [Article Influence: 11.0] [Reference Citation Analysis]
121 Stier MW, Konda VJ, Hart J, Waxman I. Post-ablation surveillance in Barrett's esophagus: A review of the literature. World J Gastroenterol 2016; 22(17): 4297-4306 [PMID: 27158198 DOI: 10.3748/wjg.v22.i17.4297] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 4] [Article Influence: 2.2] [Reference Citation Analysis]
122 Martínek J, Akiyama JI, Vacková Z, Furnari M, Savarino E, Weijs TJ, Valitova E, van der Horst S, Ruurda JP, Goense L, Triadafilopoulos G. Current treatment options for esophageal diseases. Ann N Y Acad Sci 2016;1381:139-51. [PMID: 27391867 DOI: 10.1111/nyas.13146] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
123 Krishnamoorthi R, Hargraves I, Gopalakrishnan N, Blevins CH, Priyan H, Johnson ML, Maixner KA, Wang KK, Katzka DA, Talwalkar JA, LeBlanc A, Iyer PG. Development and Pilot Testing of Decision Aid for Shared Decision Making in Barrett's Esophagus With Low-Grade Dysplasia. J Clin Gastroenterol 2021;55:36-42. [PMID: 32040049 DOI: 10.1097/MCG.0000000000001319] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
124 Verbeek RE, Vleggaar FP, Ten Kate FJ, van Baal JW, Siersema PD. Cryospray ablation using pressurized CO2 for ablation of Barrett’s esophagus with early neoplasia: early termination of a prospective series. Endosc Int Open. 2015;3:E107-E112. [PMID: 26135648 DOI: 10.1055/s-0034-1390759] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
125 Fedorova E, Watson TJ. Antireflux and Endoscopic Therapies for Barrett Esophagus and Superficial Esophageal Neoplasia. Surg Clin North Am 2021;101:391-403. [PMID: 34048760 DOI: 10.1016/j.suc.2021.03.002] [Reference Citation Analysis]
126 Komanduri S, Kahrilas PJ, Krishnan K, McGorisk T, Bidari K, Grande D, Keefer L, Pandolfino J. Recurrence of Barrett's Esophagus is Rare Following Endoscopic Eradication Therapy Coupled With Effective Reflux Control. Am J Gastroenterol. 2017;112:556-566. [PMID: 28195178 DOI: 10.1038/ajg.2017.13] [Cited by in Crossref: 37] [Cited by in F6Publishing: 33] [Article Influence: 9.3] [Reference Citation Analysis]
127 Sreenarasimhaiah J. Endoscopic applications of cryospray ablation therapy-from Barrett’s esophagus and beyond. World J Gastrointest Endosc 2016; 8(16): 546-552 [PMID: 27621766 DOI: 10.4253/wjge.v8.i16.546] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
128 Shimamura Y, Iwaya Y, Goda K, Teshima CW. Endoscopic treatment of Barrett's esophagus: What can we learn from the Western perspective? Digestive Endoscopy 2018;30:182-91. [DOI: 10.1111/den.12950] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
129 Lightdale CJ. Radiofrequency ablation for nondysplastic Barrett’s esophagus: certainly not for all. Gastrointest Endosc. 2014;80:873-876. [PMID: 25436399 DOI: 10.1016/j.gie.2014.05.331] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
130 Farina DA, Condon A, Komanduri S, Muthusamy VR. A Practical Approach to Refractory and Recurrent Barrett's Esophagus. Gastrointest Endosc Clin N Am 2021;31:183-203. [PMID: 33213795 DOI: 10.1016/j.giec.2020.09.002] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
131 Luckett T, Allamneni C, Cowley K, Eick J, Gullick A, Peter S. Length of Barrett's segment predicts failure of eradication in radiofrequency ablation for Barrett's esophagus: a retrospective cohort study. BMC Gastroenterol 2018;18:67. [PMID: 29783927 DOI: 10.1186/s12876-018-0799-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
132 Mansour NM, El-Serag HB, Anandasabapathy S. Barrett's esophagus: best practices for treatment and post-treatment surveillance. Ann Cardiothorac Surg 2017;6:75-87. [PMID: 28446996 DOI: 10.21037/acs.2017.03.05] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
133 Old OJ, Almond LM, Barr H. Barrett's oesophagus: how should we manage it? Frontline Gastroenterol 2015;6:108-16. [PMID: 28839797 DOI: 10.1136/flgastro-2014-100552] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
134 Gould JC, Wendling MR, Oeschlager BK, Mittal SK, Komanduri S, Perry KA, Cleary S, Galandiuk S, Scott DJ, Fisichella PM, Shaheen NJ, Haisley KR, Hunter JG. Advances in the Diagnosis and Treatment of Barrett's Esophagus and Early Esophageal Cancer; Summary of the Kelly and Carlos Pellegrini SSAT/SAGES Luncheon Symposium. J Gastrointest Surg 2017;21:1342-9. [PMID: 28243981 DOI: 10.1007/s11605-017-3390-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
135 Das KK, Falk GW. Long-term outcomes for cryotherapy in Barrett's esophagus with high-grade dysplasia: just cracking the ice. Gastrointest Endosc 2017;86:633-5. [PMID: 28917343 DOI: 10.1016/j.gie.2017.03.1540] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
136 Bar N, Schwartz N, Nissim M, Fliss-Isacov N, Zelber-Sagi S, Kariv R. Barrett’s esophagus with high grade dysplasia is associated with non-esophageal cancer. World J Gastroenterol 2018; 24(39): 4472-4481 [PMID: 30356981 DOI: 10.3748/wjg.v24.i39.4472] [Reference Citation Analysis]
137 Krishnamoorthi R, Singh S, Ragunathan K, A Katzka D, K Wang K, G Iyer P. Risk of recurrence of Barrett's esophagus after successful endoscopic therapy. Gastrointest Endosc. 2016;83:1090-1106.e3. [PMID: 26902843 DOI: 10.1016/j.gie.2016.02.009] [Cited by in Crossref: 52] [Cited by in F6Publishing: 46] [Article Influence: 10.4] [Reference Citation Analysis]
138 Junquera F, Fernández-Ananín S, Balagué C. Therapeutic options for early cancer of the esophagogastric junction. Cir Esp (Engl Ed) 2019;97:438-44. [PMID: 31138450 DOI: 10.1016/j.ciresp.2019.04.001] [Reference Citation Analysis]
139 Mizandari M, Kumar J, Pai M, Chikovani T, Azrumelashvili T, Reccia I, Habib N. Interventional radiofrequency ablation: A promising therapeutic modality in the management of malignant biliary and pancreatic duct obstruction. J Cancer 2018;9:629-37. [PMID: 29556320 DOI: 10.7150/jca.23280] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
140 Wang Z, Lee H, Ahsen O, Liang K, Figueiredo M, Huang Q, Fujimoto J, Mashimo H. Computer-Aided Analysis of Gland-Like Subsurface Hyposcattering Structures in Barrett’s Esophagus Using Optical Coherence Tomography. Applied Sciences 2018;8:2420. [DOI: 10.3390/app8122420] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]